Quantcast

Latest Mitral regurgitation Stories

2014-07-29 23:04:40

Global Cardiac Surgery devices market growth will be driven by extensive technological advancements, especially for transcatheter heart valve devices, reports iData Research Vancouver, BC (PRWEB) July 29, 2014 According to a new report series by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the Global Cardiac Surgery Devices Market will grow to over $8 billion by 2018. This growth will be fueled by extensive technological...

2014-07-14 23:02:06

Comprehensive study “European Market for Cardiac Surgery Devices 2014” worked out by iData Research is now available at MarketPublishers.com. According to the report, Europe’s market for cardiac surgery devices is projected to grow to over USD 3.4 billion by 2020. London, UK (PRWEB) July 14, 2014 Europe’s market for cardiac surgery devices is projected to grow to over USD 3.4 billion by 2020, with the transcatheter heart valve devices sector (composed of the transcatheter heart...

2014-07-08 00:21:05

NASDAQ: NVCN TSX: NVC VANCOUVER, July 7, 2014 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) has today been made aware through a press release issued by CardiAQ Valve Technologies ("CVT") of a stay in proceedings in one of Neovasc's European patent applications based on a lawsuit filed by CVT against Neovasc in Germany. CVT's press release implies that it won a contested proceeding before the European Patent Office, when in fact CVT took...

2014-06-11 08:29:37

Trendlines Medical and two portfolio companies of The Trendlines Group keep Trendlines on its award-winning path TEL AVIV, Israel, June 11, 2014 /PRNewswire/ -- Trendlines Medical [http://trendlines.com/medical ] received the Best Incubator award and two Trendlines portfolio companies received Best Start-up of the Year - Advanced Mem-Tech (Trendlines Agtech [http://trendlines.com/agtech ]) and MitrAssist (Trendlines Medical) - from Israel's Office of the Chief Scientist of the...

2014-05-27 12:30:37

PinnacleHealth Among Top Hospitals in United States to Offer Breakthrough Device for Patients with Mitral Valve Disease HARRISBURG, Pa., May 27, 2014 /PRNewswire/ -- Harold Lysle, Jr. of Carlisle, Pa., was considered too high risk for surgery due to the severity of his heart failure and other comorbidities. As his heart failure worsened, so did his quality of life. Harold suffered from a heart condition called mitral regurgitation, in which blood flows backward through a valve in his...

2014-05-12 23:06:30

Revolutionizing developments in biological tissue vales will drive the European transcatheter heart valve implantation market to over $1.7 Billion by 2020, Reports iData Research Vancouver, BC (PRWEB) May 12, 2014 According to a new report on the European Market for Cardiac Surgery Devices by iData Research (http://www.idataresearch.com), the leading global authority in medical device and pharmaceutical market research, the total European Cardiac Surgery Devices market is projected to...

2014-04-16 08:32:01

Funding Will Enable Initiation of Blinded, Randomized Clinical Trial and Expanded Commercialization of CARILLON® Mitral Contour System® KIRKLAND, Wash., April 16, 2014 /PRNewswire/ -- Cardiac Dimensions(®),( )Inc. today announced the completion of a $20 million financing. M. H. Carnegie & Co. and Lumira Capital led the financing as part of an international syndicate of institutional investors from Australia, the U.S. and Canada. The financing follows the company's completion...

2014-04-09 16:26:11

ROSEVILLE, Minn., April 9, 2014 /PRNewswire/ -- Tendyne Holdings, Inc. ("Tendyne"), a privately held clinical stage medical device company developing technologies for transcatheter mitral valve replacement, announced today that it has secured $25 million in an oversubscribed Series C financing led by Apple Tree Partners, along with Boulle Group members and other existing investors. Proceeds will be used for validation of Tendyne's novel Transcatheter Mitral Valve Implant to treat...

2014-02-19 12:28:22

Sets Stage for Expanded Adoption Of CARILLON® Mitral Contour System® KIRKLAND, Wash., Feb. 19, 2014 /PRNewswire/ -- Cardiac Dimensions(®),( )Inc. today announced that the Company's CARILLON(® )Mitral Contour System(® )has received German Neue Untersuchungs und Behandlungsmethoden (NUB) Status 1 approval across 120 leading hospitals in Germany, a decision from German regulators that may positively influence reimbursement from insurance companies for the costs of CARILLON...

2014-02-18 12:30:32

- Harpoon Has Raised More Than $300,000 in Competitive Grants and Award Funding in Less Than a Year - BALTIMORE, Feb. 18, 2014 /PRNewswire/ -- University of Maryland (UM) Ventures and Harpoon Medical, Inc. announced today that Harpoon Medical has obtained exclusive rights to a portfolio of technologies for cardiac valve repair from the University of Maryland, Baltimore (UMB). The licensed technology was developed in the Division of Cardiac Surgery at The University of Maryland School...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related